REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unaudited Financial Statements for the Year Ended 31 March 2022 |
|
for |
|
PharmaSEAL International Limited |
REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unaudited Financial Statements for the Year Ended 31 March 2022 |
|
for |
|
PharmaSEAL International Limited |
PharmaSEAL International Limited (Registered number: 09993255) |
|
Contents of the Financial Statements |
for the Year Ended 31 March 2022 |
|
|
|
|
|
|
|
|
|
|
Page |
|
Company Information | 1 |
|
Balance Sheet | 2 |
|
Notes to the Financial Statements | 4 |
|
PharmaSEAL International Limited |
|
|
Company Information |
for the Year Ended 31 March 2022 |
|
|
|
|
|
|
|
DIRECTORS: |
|
|
|
|
|
|
|
|
SECRETARY: |
|
|
|
|
|
REGISTERED OFFICE: |
|
|
|
|
|
|
|
|
|
|
REGISTERED NUMBER: |
|
|
|
|
|
|
ACCOUNTANTS: |
|
Chartered Accountants |
83 Park Road |
Chilwell |
Nottingham |
NG9 4DE |
PharmaSEAL International Limited (Registered number: 09993255) |
|
|
Balance Sheet |
31 March 2022 |
|
31.3.22 | 31.3.21 |
Notes | £ | £ | £ | £ |
FIXED ASSETS |
Tangible assets | 4 |
|
|
|
CURRENT ASSETS |
Debtors | 5 |
|
|
Cash at bank |
|
|
|
|
CREDITORS |
Amounts falling due within one year | 6 |
|
|
NET CURRENT ASSETS |
|
|
TOTAL ASSETS LESS CURRENT
LIABILITIES |
|
|
|
CREDITORS |
Amounts falling due after more than one
year |
7 |
|
|
NET ASSETS |
|
|
|
CAPITAL AND RESERVES |
Called up share capital | 8 |
|
|
Share premium | 9 |
|
|
Retained earnings | 9 | ( |
) | ( |
) |
SHAREHOLDERS' FUNDS |
|
|
|
|
|
|
|
The directors acknowledge their responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
PharmaSEAL International Limited (Registered number: 09993255) |
|
|
Balance Sheet - continued |
31 March 2022 |
|
|
|
|
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
|
The financial statements were approved by the Board of Directors and authorised for issue on
|
|
|
|
|
|
|
|
PharmaSEAL International Limited (Registered number: 09993255) |
|
|
Notes to the Financial Statements |
for the Year Ended 31 March 2022 |
|
|
1. | STATUTORY INFORMATION |
|
PharmaSEAL International Limited is a
|
|
2. | ACCOUNTING POLICIES |
|
Basis of preparing the financial statements |
|
|
Turnover |
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
|
Tangible fixed assets |
|
Computer equipment | - |
|
|
Taxation |
Taxation for the year comprises current tax which is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. Current taxation assets and liabilities are not discounted. |
|
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
|
Hire purchase and leasing commitments |
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease. |
|
Pension costs and other post-retirement benefits |
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
|
3. | EMPLOYEES AND DIRECTORS |
|
The average number of employees during the year was
|
PharmaSEAL International Limited (Registered number: 09993255) |
|
|
Notes to the Financial Statements - continued |
for the Year Ended 31 March 2022 |
|
|
4. | TANGIBLE FIXED ASSETS |
Plant and |
machinery |
etc |
£ |
COST |
At 1 April 2021 |
|
Additions |
|
At 31 March 2022 |
|
DEPRECIATION |
At 1 April 2021 |
|
Charge for year |
|
At 31 March 2022 |
|
NET BOOK VALUE |
At 31 March 2022 |
|
At 31 March 2021 |
|
|
5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
31.3.22 | 31.3.21 |
£ | £ |
Trade debtors |
|
|
Other debtors |
|
|
Directors' current accounts | - | 1 |
Tax |
|
|
VAT |
|
|
Prepayments |
|
|
|
|
|
6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
31.3.22 | 31.3.21 |
£ | £ |
Bank loans and overdrafts |
|
|
Trade creditors |
|
|
Social security and other taxes |
|
|
Other creditors |
|
|
Deferred income |
|
|
Accrued expenses |
|
|
|
|
PharmaSEAL International Limited (Registered number: 09993255) |
|
|
Notes to the Financial Statements - continued |
for the Year Ended 31 March 2022 |
|
|
7. |
CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR |
31.3.22 | 31.3.21 |
£ | £ |
Bank loans - 1-2 years |
|
|
Bank loans - 2-5 years |
|
|
|
|
|
8. | CALLED UP SHARE CAPITAL |
|
|
|
|
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 31.3.22 | 31.3.21 |
value: | £ | £ |
|
Ordinary | £0.00001 | 1 | 1 |
|
A Ordinary | £0.00001 | 4 | 4 |
5 | 5 |
|
9. | RESERVES |
Retained | Share |
earnings | premium | Totals |
£ | £ | £ |
|
At 1 April 2021 | ( |
) |
|
319,858 |
Deficit for the year | ( |
) | ( |
) |
At 31 March 2022 | ( |
) |
|
6,221 |
|
10. | GOING CONCERN |
|
In common with other start-up companies, at the balance sheet date, liabilities exceeded assets and cash reserves. The director's are in discussion with prospective investors and firmly believe that they will be able to secure sufficient funds from a combination of trading activities, loans, grants and existing and new investors to allow the company to meet its obligations as they fall due. Accordingly, the accounts have been prepared on a going concern basis. |